JPMORGAN CHASE & CO - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 21 filers reported holding SOLENO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$979,024
+3765376.9%
33,176
+552833.3%
0.00%
Q2 2023$26
-100.0%
6
-100.0%
0.00%
Q1 2023$150,00069,875
+1164483.3%
0.00%
Q4 2022$06
-40.0%
0.00%
Q3 2022$0100.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 422,489$904,1270.33%
Clayton Partners LLC 92,772$198,5320.19%
Nantahala Capital Management 699,364$1,496,6390.12%
Worth Venture Partners, LLC 103,913$222,3740.11%
Carlyle Group Inc. 1,201,506$2,535,1780.08%
J. Goldman & Co LP 269,443$576,6080.02%
BANK OF AMERICA CORP /DE/ 2,093$4,4790.00%
WELLS FARGO & COMPANY/MN 38$810.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 37$790.00%
View complete list of SOLENO THERAPEUTICS INC shareholders